Organizing pneumonia (cryptogenic organizing pneumonia — COP, formerly BOOP) is an interstitial lung disease characterized by fibrous tissue proliferation (Masson bodies) in alveolar spaces and distal airways. It is a non-infectious, steroid-responsive process. The cryptogenic (idiopathic) form is most common, but many causes including infections, drugs, autoimmune diseases, radiation therapy, and organ transplantation can lead to secondary organizing pneumonia. The reverse halo sign (atoll sign) on CT is a pathognomonic finding.
Age Range
40-70
Peak Age
55
Gender
Equal
Prevalence
Uncommon
The fundamental histopathologic feature of organizing pneumonia is the formation of fibrous tissue plugs (Masson bodies or intraluminal polyps) in alveolar spaces, alveolar ducts, and respiratory bronchioles. These plugs consist of loose connective tissue, fibroblasts, and myofibroblasts. Alveolar walls are relatively preserved — this feature distinguishes organizing pneumonia from usual interstitial pneumonia (UIP). Consolidation areas on CT reflect filling of alveolar spaces by Masson bodies. The reverse halo sign (atoll sign) forms because the peripheral ring of consolidation represents peripheral granulation tissue while the central ground-glass area represents less affected alveolar parenchyma. The migratory pattern — lesions regressing in one area while appearing in another — reflects the dynamic inflammatory process of organizing pneumonia. Dramatic response to steroid therapy indicates the fibrosis is reversible.
A crescent or ring of consolidation ≥2mm thick surrounding a central ground-glass area. Considered pathognomonic for organizing pneumonia. The atoll name derives from the morphological similarity to a lagoon (ground-glass = low density) in the center surrounded by coral reefs (consolidation = high density). Rarely, it may also be seen in pulmonary infarction, granulomatosis with polyangiitis, and invasive aspergillosis, but organizing pneumonia should be the first diagnosis considered.
Reverse halo sign (atoll sign): a crescent or ring of consolidation surrounding a central ground-glass area. Pathognomonic finding for organizing pneumonia. The outer consolidation ring is typically ≥2mm thick and crescentic in shape.
Report Sentence
A ring of consolidation surrounding a central ground-glass area (reverse halo sign / atoll sign) is identified, and this finding is pathognomonic for organizing pneumonia.
Patchy consolidation areas with peribronchovascular distribution: bilateral, asymmetric consolidation along bronchovascular bundles and in subpleural regions. This distribution pattern is the most typical CT finding of organizing pneumonia and predominates in lower lobes.
Report Sentence
Patchy consolidation areas with peribronchovascular and subpleural distribution showing lower lobe predominance are observed in both lungs, consistent with organizing pneumonia.
Migratory pattern: on serial CT follow-ups, consolidation areas regress in one location while new consolidation appears at a different location. This pattern is highly characteristic of organizing pneumonia and is an important distinguishing finding from infectious pneumonia.
Report Sentence
Comparison with prior CT shows migration of consolidation areas (migratory pattern), strongly supporting the diagnosis of organizing pneumonia.
Band-like (linear) opacities: linear/band-shaped consolidation or ground-glass areas parallel to the pleural surface or with peribronchovascular course. Also described as perilobular pattern. This pattern is common in organizing pneumonia and is particularly prominent in subpleural regions.
Report Sentence
Band-like opacities parallel to the pleural surface in subpleural regions (perilobular pattern) are observed, consistent with organizing pneumonia.
Homogeneous or mildly heterogeneous enhancement in consolidation areas on contrast-enhanced CT. Reflects the rich vascular structure of granulation tissue in organizing pneumonia. The degree of enhancement is generally moderate and may be more prominent at the periphery of cavitary lesions.
Report Sentence
Homogeneous enhancement is observed in consolidation areas on contrast-enhanced series, consistent with vascularized granulation tissue.
Ground-glass opacities: areas of ground-glass density seen together with or independent of consolidation areas. In organizing pneumonia, ground-glass opacities reflect alveolar wall edema and early stages of mild alveolar filling. The combination of consolidation and ground-glass is typical.
Report Sentence
Ground-glass opacities are observed surrounding consolidation areas and independently, reflecting early/transitional phase findings of organizing pneumonia.
Criteria
Organizing pneumonia with no identifiable cause (idiopathic). Classified within idiopathic interstitial pneumonias.
Distinct Features
Most common form (60-70%). Typically age 50-60, equal gender distribution. Subacute onset (weeks). Dramatic response to steroid therapy but 25% relapse rate. Bilateral, lower lobe predominant, peribronchovascular distribution.
Criteria
Organizing pneumonia secondary to infection (viral, bacterial). Post-COVID-19 organizing pneumonia is an important subgroup.
Distinct Features
Should be considered when symptoms persist 2-6 weeks after infection. May occur in 5-10% of patients post-COVID-19. If infection findings do not resolve in expected timeframe, organizing pneumonia pattern should be sought on CT. Treatment similar to COP (steroids).
Criteria
Organizing pneumonia variant appearing as a single focal consolidation or nodule/mass. May be confused with lung cancer.
Distinct Features
Appears as solitary nodule/mass — may mimic lung cancer. Usually ≤30mm, well-defined or mildly irregular contours. May show moderate FDG uptake on PET-CT (false positive). Biopsy is usually required. Complete response with surgical resection or steroid therapy.
Criteria
Organizing pneumonia secondary to drug exposure (amiodarone, bleomycin, methotrexate, nitrofurantoin, immunotherapy).
Distinct Features
Drug exposure history is critical. Organizing pneumonia with immunotherapy (checkpoint inhibitors) is an increasing concern. Drug discontinuation + steroid therapy required. CT pattern similar to COP but some drugs may have specific additional findings (amiodarone — high density).
Distinguishing Feature
Adenocarcinoma typically appears as a solitary spiculated mass/nodule, grows progressively, does not show migratory pattern. Unlike organizing pneumonia, does not respond to steroids. High FDG avidity on PET-CT. However, focal organizing pneumonia may mimic adenocarcinoma — biopsy may be required.
Distinguishing Feature
Pulmonary lymphoma may resemble organizing pneumonia with consolidation, nodules, and air bronchograms. However, in lymphoma, mediastinal/hilar lymphadenopathy is common, pleural effusion may accompany, and response to steroid therapy is not as dramatic as in organizing pneumonia. Intense FDG uptake on PET-CT supports lymphoma.
Distinguishing Feature
Mucinous adenocarcinoma in pneumonic form may resemble organizing pneumonia with bilateral consolidation. However, CT angiogram sign (prominent vessels within consolidation), low HU values (mucin content), and progressive course in mucinous adenocarcinoma are distinguishing. Does not respond to steroids.
Distinguishing Feature
Lung abscess appears as a cavitary lesion — distinguished from organizing pneumonia by thick irregular wall and air-fluid level. Abscess shows intense rim enhancement, septic clinical picture (high fever, leukocytosis), and antibiotic response. Cavitation in organizing pneumonia is rare and if present, thin-walled.
Urgency
routineManagement
medicalBiopsy
Not NeededFollow-up
3-monthOrganizing pneumonia responds dramatically to steroid therapy — prednisolone 0.75-1 mg/kg/day initially, gradual taper over 6-12 months. Radiological improvement typically begins within 1-2 weeks, complete resolution in 3-6 months. However, early steroid discontinuation increases relapse risk (25%). With typical CT findings (reverse halo, migratory pattern) and compatible clinical picture (subacute onset, no antibiotic response), empiric steroids may be started — biopsy is not always necessary. In atypical or focal forms, biopsy (transbronchial or surgical) may be required.
COP responds very well to steroid therapy (80-90%). Treatment is usually maintained for 6-12 months. Relapse may occur (when steroids are tapered). Biopsy may be needed to exclude malignancy.